Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Case Reports in Immunology|December 21, 2017
Gain-of-Function Mutations in STAT1: A Recently Defined Cause for Chronic Mucocutaneous Candidiasis Disease Mimicking Combined ImmunodeficienciesSanem Eren Akarcan, Ezgi Ulusoy Severcan, Neslihan Edeer Karaca, et al.
Case Reports in Immunology|September 10, 2020
The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term SurvivorYike Jiang, Mihail Firan, Sarada L Nandiwada, et al.
Case Reports in Immunology|July 5, 2022
Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell TransplantationDenis F Noubouossie, Mohammed I A Zaanona, Luciano J Costa, et al.
Case Reports in Immunology|December 21, 2020
On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-UpSnezhina Mihailova Kandilarova, Spaska Stoyneva Lesichkova, Nevena Todorova Gesheva, et al.
Case Reports in Immunology|February 25, 2021
Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome"Cesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, et al.
Case Reports in Immunology|November 8, 2016
Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative ColitisMatthew Chak Hin Szeto, Metin Devrim Yalçın, Abdul Khan, et al.
Case Reports in Immunology|July 30, 2019
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE SyndromeCesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, et al.
Case Reports in Immunology|December 16, 2016
Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial DiseaseWilliam Rae, Yifang Gao, Efrem Eren, et al.
Case Reports in Immunology|February 17, 2015
Successful desensitization of a patient with rituximab hypersensitivityPinar Ataca, Erden Atilla, Resat Kendir, et al.
Pageof 18